154 related articles for article (PubMed ID: 25241896)
1. UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.
Itkonen HM; Engedal N; Babaie E; Luhr M; Guldvik IJ; Minner S; Hohloch J; Tsourlakis MC; Schlomm T; Mills IG
Oncogene; 2015 Jul; 34(28):3744-50. PubMed ID: 25241896
[TBL] [Abstract][Full Text] [Related]
2. N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor.
Itkonen HM; Mills IG
PLoS One; 2013; 8(5):e65016. PubMed ID: 23724116
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel Inhibitors Targeting Multi-UDP-hexose Pyrophosphorylases as Anticancer Agents.
Yang Y; Vankayalapati H; Tang M; Zheng Y; Li Y; Ma C; Lai K
Molecules; 2020 Feb; 25(3):. PubMed ID: 32028604
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells.
Ben Aicha S; Lessard J; Pelletier M; Fournier A; Calvo E; Labrie C
Physiol Genomics; 2007 Oct; 31(2):295-305. PubMed ID: 17712038
[TBL] [Abstract][Full Text] [Related]
6. Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers.
Chen R; Zeng X; Zhang R; Huang J; Kuang X; Yang J; Liu J; Tawfik O; Thrasher JB; Li B
Urol Oncol; 2014 Jul; 32(5):524-36. PubMed ID: 24054868
[TBL] [Abstract][Full Text] [Related]
7. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Itkonen HM; Gorad SS; Duveau DY; Martin SE; Barkovskaya A; Bathen TF; Moestue SA; Mills IG
Oncotarget; 2016 Mar; 7(11):12464-76. PubMed ID: 26824323
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions.
Saeed K; Östling P; Björkman M; Mirtti T; Alanen K; Vesterinen T; Sankila A; Lundin J; Lundin M; Rannikko A; Nordling S; Mpindi JP; Kohonen P; Iljin K; Kallioniemi O; Rantala JK
Int J Cancer; 2015 Jun; 136(11):2535-45. PubMed ID: 25359680
[TBL] [Abstract][Full Text] [Related]
10. A missense mutation in a patient with developmental delay affects the activity and structure of the hexosamine biosynthetic pathway enzyme AGX1.
Chen X; Raimi OG; Ferenbach AT; van Aalten DMF
FEBS Lett; 2021 Jan; 595(1):110-122. PubMed ID: 33098688
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability.
Munkley J; Vodak D; Livermore KE; James K; Wilson BT; Knight B; Mccullagh P; Mcgrath J; Crundwell M; Harries LW; Leung HY; Robson CN; Mills IG; Rajan P; Elliott DJ
EBioMedicine; 2016 Jun; 8():103-116. PubMed ID: 27428423
[TBL] [Abstract][Full Text] [Related]
12. Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry.
Abdel Rahman AM; Ryczko M; Pawling J; Dennis JW
ACS Chem Biol; 2013 Sep; 8(9):2053-62. PubMed ID: 23875632
[TBL] [Abstract][Full Text] [Related]
13. High glucose induces N-linked glycosylation-mediated functional upregulation and overexpression of Ca
Fukami K; Asano E; Ueda M; Sekiguchi F; Yoshida S; Kawabata A
J Pharmacol Sci; 2017 Jan; 133(1):57-60. PubMed ID: 28081948
[TBL] [Abstract][Full Text] [Related]
14. 2-Deoxy-d-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic cancer cells.
Ishino K; Kudo M; Peng WX; Kure S; Kawahara K; Teduka K; Kawamoto Y; Kitamura T; Fujii T; Yamamoto T; Wada R; Naito Z
Biochem Biophys Res Commun; 2018 Jun; 501(3):668-673. PubMed ID: 29753740
[TBL] [Abstract][Full Text] [Related]
15. UDP-
Wang Z; Wang Q; Wei L; Shi Y; Li T; Hu K; Liu S; Zhong H; Liao J; Li Y; Zhang H; Huang Y
Front Plant Sci; 2021; 12():685102. PubMed ID: 34249055
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
[TBL] [Abstract][Full Text] [Related]
17. Human heterochromatin protein 1 isoform HP1beta enhances androgen receptor activity and is implicated in prostate cancer growth.
Shiota M; Song Y; Yokomizo A; Tada Y; Kuroiwa K; Eto M; Oda Y; Inokuchi J; Uchiumi T; Fujimoto N; Seki N; Naito S
Endocr Relat Cancer; 2010 Jun; 17(2):455-67. PubMed ID: 20308360
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression.
Lee JW; Kim GY; Kim JH
Biochem Biophys Res Commun; 2012 Apr; 420(2):428-33. PubMed ID: 22426480
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-κB and CHOP expression.
Huong PT; Moon DO; Kim SO; Kim KE; Jeong SJ; Lee KW; Lee KS; Jang JH; Erikson RL; Ahn JS; Kim BY
Cell Signal; 2011 May; 23(5):857-65. PubMed ID: 21276850
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation is a global target for androgen control in prostate cancer cells.
Munkley J
Endocr Relat Cancer; 2017 Mar; 24(3):R49-R64. PubMed ID: 28159857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
